Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aptose Biosciences (APS) just unveiled an update.
On June 14, 2024, a press release was issued by the Registrant, detailing information that, as per the rules outlined, will not be considered officially “filed” under the Securities Exchange Act of 1934. This distinction implies that the content should not automatically be integrated into any legal filings unless explicitly referenced in such documents.
Find detailed analytics on APS stock on TipRanks’ Stock Analysis page.